---
layout: entry
title: "High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019"
link: "https://doi.org/10.1093/ofid/ofaa102"
author:
- Cao, Wei; Liu, Xiaosheng; Bai, Tao; Fan, Hongwei; Hong, Ke; Song, Hui; Han, Yang; Lin, Ling; Ruan, Lianguo; Li, Taisheng

summary:
- "the outbreak of coronavirus disease 2019 has spread rapidly in China. No definite effective treatment has been identified. 3 patients with severe COVID-19 received high-dose intravenous immunoglobulin (IVIg) with satisfactory recovery. randomized studies should be considered in deteriorating patients infected with the disease. We reported on 3 patients who received high dose IVIg."

original:
- "The outbreak of coronavirus disease 2019 (COVID-19) has spread rapidly in China. Until now, no definite effective treatment has been identified. We reported on 3 patients with severe COVID-19 who received high-dose intravenous immunoglobulin (IVIg) with satisfactory recovery. Based on these observations, randomized studies of high-dose IVIg should be considered in deteriorating patients infected with COVID-19."
---

